
Glimkaire-VM1 Tablet SR
Marketer
SAG Health Science Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimkaire-VM1 Tablet SR
Diabex Duo SR tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. These tablets help regulate blood glucose in diabetic patients. Diabex Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-controlled blood sugar; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor; lifestyle choices are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Be aware of these symptoms and have readily available fast-acting glucose sources (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are advised by your doctor.
Primary Ingredients of Glimkaire-VM1 Tablet SR
The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Glimkaire-VM1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimkaire-VM1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimkaire-VM1 Tablet SR whole; do not break, crush, or chew it. Administer this medication on an empty stomach.
Common Side effects of Glimkaire-VM1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimkaire-VM1 Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimkaire-VM1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.
How Glimkaire-VM1 Tablet SR works:
The extended-release tablet, Glimkaire-VM1, contains a triple-drug regimen for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimkaire-VM1 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimkaire-VM1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimkaire-VM1 tablet likely poses a risk during lactation. Preliminary human evidence indicates potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimkaire-VM1 Tablet SR is inadvisable for individuals with kidney impairment and should be avoided. Seek medical advice before use. Specifically, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Glimkaire-VM1 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician for guidance. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Glimkaire-VM1 Tablet SR :
Should you forget to take a Glimkaire-VM1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glimkaire-VM1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
